# Free Fatty Acid Effects In Type 2 Diabetes

> **NCT07677995** · NA · ENROLLING_BY_INVITATION · sponsor: **University of Ulster** · enrollment: 60 (estimated)

## Conditions studied

- Type 2 Diabetes
- Cardiovascular Disease
- Omega-3 Fatty Acids

## Interventions

- **DIETARY_SUPPLEMENT:** Omega-3 Fatty Acids
- **DRUG:** Semaglutide 0.25 mg
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07677995
- **Lead sponsor:** University of Ulster
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-09
- **Primary completion:** 2026-12
- **Final completion:** 2027-02
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07677995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07677995, "Free Fatty Acid Effects In Type 2 Diabetes". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07677995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
